bioRxiv/medRxiv TRiP Review Activity

412 Reviews — All Partners — Cancer Biology

Most recent first Previous |  Page 3: Articles 21-30  | Next

Monitoring of Cell-free Human Papillomavirus DNA in Metastatic or Recurrent Cervical Cancer: Clinical Significance and Treatment Implications
Yin, Z., Feng, T., Xu, Q., Dai, W., Ni, M., Ni, J., Lou, H.
10.1101/2024.09.16.613189 — Posted: 2024-09-18 — Discussion: 2025-07-22  eLife
Interplay of YEATS2 and GCDH mediates histone crotonylation and drives EMT in head and neck cancer
Pant, D., KAKANI, P., Joshi, R., Agrawal, S., Samaiya, A., Shukla, S.
10.1101/2024.09.24.614679 — Posted: 2024-09-26 — Discussion: 2025-07-21  eLife
Deciphering the tumor-infiltrating CD73+ regulatory gammadelta T cell ecosystem associated with poor survival of patients with ovarian cancer
LAFONT, V., Chabab, G., Michaud, H.-A., Dejou, C., Chauvin, M., Chepeaux, L.-A., Glasson, Y., Boissiere, F., Lenain, M., Dume, A.-S., Sarrant, P., Chemin, G., Wadja, P., Dubois, B., MacManus, A., Colombo, P.-E., Fabbro, M., Bonnefoy, N.
10.1101/2024.12.09.627460 — Posted: 2024-12-12 — Discussion: 2025-07-16  Review Commons
Altered thymic niche synergistically drives the massive proliferation of malignant thymocytes
Tsingos, E., Dick, A. M., Bajoghli, B.
10.1101/2024.06.25.600590 — Posted: 2024-06-29 — Discussion: 2025-07-08  eLife
The long noncoding RNA lnc-FANCI-2 restricts RAS signaling and phosphorylation of Akt and Erk in HPV16-infected cervical cancer cells
Liu, H., Yu, L., Majerciak, V., Meyer, T., Yi, M., Johnson, P. F., Cam, M., Lowy, D. R., Zheng, Z.-M.
10.1101/2024.02.01.578320 — Posted: 2024-02-02 — Discussion: 2025-07-03  eLife
Subtypes and proliferation patterns of small intestine neuroendocrine tumors revealed by single cell RNA sequencing
Somech, E., Halder, D., Spitzer, A., Barbolin, C., Tyler, M., Halperin, R., Biton, M., Tirosh, A., Tirosh, I.
10.1101/2024.07.29.605642 — Posted: 2024-07-30 — Discussion: 2025-07-03  eLife
Recurrent cancer-associated ERBB4 mutations are transforming and confer resistance to targeted therapies
Ojala, V. K., Ahonen, S., Tuohisto-Kokko, A., Esparta, O., Suominen, P., Jokilammi, A., Farahani, I., Chakroborty, D., Dibus, N., Boettcher, S., Airenne, T. T., Johnson, M. S., Eli, L. D., Elenius, K., Kurppa, K. J.
10.1101/2024.12.19.626686 — Posted: 2024-12-20 — Discussion: 2025-06-29  Review Commons
Cancer cells differentially modulate mitochondrial respiration to alter redox state and enable biomass synthesis in nutrient-limited environments
Chang, S. M., Bin Munim, M., Trojan, S. E., Shevzov-Zebrun, A., Abbott, K. L., Vander Heiden, M. G.
10.1101/2025.05.09.653205 — Posted: 2025-05-10 — Discussion: 2025-06-27  eLife
p53-induced RNA-binding protein ZMAT3 inhibits transcription of a hexokinase to suppress mitochondrial respiration
Kumar, R., Couly, S., Muys, B. R., Li, X. L., Grammatikakis, I., Singh, R., Guest, M., Wen, X., Tang, W., Ambs, S., Jenkins, L. M., Pehrsson, E. C., Chari, R., Su, T.-P., Lal, A.
10.1101/2025.05.12.653341 — Posted: 2025-05-13 — Discussion: 2025-06-26  eLife
Design of combination therapeutics from protein response to drugs in ovarian cancer cells
Franz, A., Shen, C., Coscia, F., Munroe, K., Charaoui, L., Korkut, A., Mann, M., Luna, A., Sander, C.
10.1101/2025.04.28.651139 — Posted: 2025-05-02 — Discussion: 2025-06-25  eLife

Evaluation Sources